Grégory Neveu

1.3k total citations
16 papers, 755 citations indexed

About

Grégory Neveu is a scholar working on Molecular Biology, Hepatology and Infectious Diseases. According to data from OpenAlex, Grégory Neveu has authored 16 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Grégory Neveu's work include Hepatitis C virus research (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and HIV Research and Treatment (3 papers). Grégory Neveu is often cited by papers focused on Hepatitis C virus research (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and HIV Research and Treatment (3 papers). Grégory Neveu collaborates with scholars based in United States, France and Belgium. Grégory Neveu's co-authors include Shirit Einav, Rina Barouch‐Bentov, Amotz Ziv-Av, Yves Jacob, Doron Gerber, Elena Bekerman, Jon Mulholland, Fei Xiao, Steven De Jonghe and Piet Herdewijn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Grégory Neveu

16 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grégory Neveu United States 12 269 249 218 160 150 16 755
Rina Barouch‐Bentov United States 14 407 1.5× 314 1.3× 162 0.7× 239 1.5× 99 0.7× 19 1.1k
Stanford Schor United States 10 215 0.8× 165 0.7× 123 0.6× 99 0.6× 37 0.2× 11 523
Joachim Jaeger United States 15 472 1.8× 124 0.5× 231 1.1× 60 0.4× 254 1.7× 21 830
Linda Bartholomew Italy 11 237 0.9× 364 1.5× 505 2.3× 82 0.5× 668 4.5× 14 962
Patrick Labonté Canada 14 213 0.8× 124 0.5× 446 2.0× 87 0.5× 303 2.0× 35 839
Christian Castro United States 14 634 2.4× 371 1.5× 295 1.4× 64 0.4× 276 1.8× 23 1.2k
Miguel Mata United States 8 435 1.6× 204 0.8× 154 0.7× 210 1.3× 32 0.2× 8 766
Patrick Eldin France 12 311 1.2× 118 0.5× 121 0.6× 179 1.1× 27 0.2× 29 682
Dorjbal Dorjsuren United States 20 797 3.0× 71 0.3× 311 1.4× 55 0.3× 128 0.9× 30 1.1k
Adam Gates United States 11 622 2.3× 386 1.6× 238 1.1× 47 0.3× 191 1.3× 13 1.2k

Countries citing papers authored by Grégory Neveu

Since Specialization
Citations

This map shows the geographic impact of Grégory Neveu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grégory Neveu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grégory Neveu more than expected).

Fields of papers citing papers by Grégory Neveu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grégory Neveu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grégory Neveu. The network helps show where Grégory Neveu may publish in the future.

Co-authorship network of co-authors of Grégory Neveu

This figure shows the co-authorship network connecting the top 25 collaborators of Grégory Neveu. A scholar is included among the top collaborators of Grégory Neveu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grégory Neveu. Grégory Neveu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lahlali, Thomas, Grégory Neveu, Christine C. Siska, et al.. (2024). AI-based antibody discovery platform identifies novel, diverse, and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strains. PubMed. 7(4). 307–323. 4 indexed citations
2.
Schor, Stanford, Szu‐Yuan Pu, Vlad Nicolaescu, et al.. (2022). The cargo adapter protein CLINT1 is phosphorylated by the Numb-associated kinase BIKE and mediates dengue virus infection. Journal of Biological Chemistry. 298(6). 101956–101956. 5 indexed citations
3.
Martínez, María Guadalupe, Emmanuel Combe, Philippe Mangeot, et al.. (2022). CRISPR-Cas9 Targeting of Hepatitis B Virus Covalently Closed Circular DNA Generates Transcriptionally Active Episomal Variants. mBio. 13(2). e0288821–e0288821. 28 indexed citations
4.
Freitas, Natália, Solène Denolly, Camille Lévy, et al.. (2020). The interplays between Crimean-Congo hemorrhagic fever virus (CCHFV) M segment-encoded accessory proteins and structural proteins promote virus assembly and infectivity. PLoS Pathogens. 16(9). e1008850–e1008850. 37 indexed citations
5.
Rivoire, Michel, Grégory Neveu, Antoine Alam, et al.. (2020). Full-length 5'RACE identifies all major HBV transcripts in HBV-infected hepatocytes and patient serum. Journal of Hepatology. 73(1). 40–51. 60 indexed citations
6.
Martínez, María Guadalupe, Grégory Neveu, Antoine Alam, et al.. (2020). Targeting hepatitis B virus with CRISPR/Cas9 approach. Journal of Hepatology. 73. S841–S842. 3 indexed citations
7.
Xiao, Fei, Stanley Wang, Rina Barouch‐Bentov, et al.. (2018). Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus Release. mBio. 9(2). 30 indexed citations
8.
Bekerman, Elena, Grégory Neveu, Ana Shulla, et al.. (2017). Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects. Journal of Clinical Investigation. 127(4). 1338–1352. 172 indexed citations
10.
Plissonnier, Marie‐Laure, Thomas Lahlali, Maud Michelet, et al.. (2016). Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus. PLoS Biology. 14(3). e1002421–e1002421. 14 indexed citations
11.
Glick, Yaïr, Nir Drayman, Grégory Neveu, et al.. (2016). Pathogen receptor discovery with a microfluidic human membrane protein array. Proceedings of the National Academy of Sciences. 113(16). 4344–4349. 16 indexed citations
12.
Vidalain, Pierre‐Olivier, Yves Jacob, Marne C. Hagemeijer, et al.. (2015). A Field-Proven Yeast Two-Hybrid Protocol Used to Identify Coronavirus–Host Protein–Protein Interactions. Methods in molecular biology. 1282. 213–229. 11 indexed citations
13.
Chang, Lei, Elena Bekerman, Grégory Neveu, et al.. (2015). Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents. Journal of Medicinal Chemistry. 58(8). 3393–3410. 48 indexed citations
14.
Neveu, Grégory, et al.. (2015). AP-2-Associated Protein Kinase 1 and Cyclin G-Associated Kinase Regulate Hepatitis C Virus Entry and Are Potential Drug Targets. Journal of Virology. 89(8). 4387–4404. 100 indexed citations
15.
Neveu, Grégory, Patricia Cassonnet, Pierre‐Olivier Vidalain, et al.. (2012). Comparative analysis of virus–host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase. Methods. 58(4). 349–359. 56 indexed citations
16.
Neveu, Grégory, Rina Barouch‐Bentov, Amotz Ziv-Av, et al.. (2012). Identification and Targeting of an Interaction between a Tyrosine Motif within Hepatitis C Virus Core Protein and AP2M1 Essential for Viral Assembly. PLoS Pathogens. 8(8). e1002845–e1002845. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026